文献速递主动脉疾病

口服克拉霉素可预防主动脉瘤的进展与破裂

The oral administration of clarithromycin prevents the progression and rupture of aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2018-03-14

在血管紧张素II灌注的载脂蛋白E缺陷小鼠中,口服克拉霉素(100 mg/kg/d)显著抑制主动脉直径扩张并完全避免破裂死亡(0% vs 38%),同时减轻弹性蛋白降解、巨噬细胞浸润、MMP-2/MMP-9活性及炎症因子水平。

要点

  • 克拉霉素组主动脉直径显著受抑(P < .001),破裂死亡0例 vs 对照组5例(38%)(P < .01)。
  • 克拉霉素显著抑制弹性蛋白降解(56.3% vs 16.5%;P < .001)并减少炎症巨噬细胞浸润(0.05 vs 0.16;P < .01)。
  • 克拉霉素组MMP-2(0.15 vs 0.56;P < .01)和MMP-9(0.12 vs 0.60;P < .01)酶活性显著降低。

核心结论

  • 克拉霉素通过抑制炎症巨噬细胞浸润、降低MMP-2和MMP-9活性以及抑制NF-κB磷酸化相关的弹性蛋白降解,抑制主动脉瘤的进展与破裂。

研究设计与样本

  • 雄性载脂蛋白E缺陷小鼠(28-30周龄)接受血管紧张素II输注28天,每日口服克拉霉素(100 mg/kg/d)或生理盐水(对照),克拉霉素组n=13,对照组n=13。

主要发现

  • 克拉霉素组主动脉直径显著受抑(P < .001)。
  • 克拉霉素组无破裂死亡,对照组5例死亡(38%)(P < .01)。
  • 克拉霉素显著抑制主动脉弹性蛋白降解(56.3% vs 16.5%;P < .001)。
  • 克拉霉素组炎症巨噬细胞浸润减少(0.05 vs 0.16;P < .01)。
  • 克拉霉素组MMP-2(0.15 vs 0.56;P < .01)和MMP-9(0.12 vs 0.60;P < .01)酶活性显著降低,白介素1β(346.6 vs 1066.0;P < .05)、白介素6(128.4 vs 346.2;P < .05)水平及NF-κB磷酸化(0.3 vs 2.0;P < .01)亦降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The pathogenesis of aortic aneurysm (AA) is associated with chronic inflammation in the aortic wall with increased levels of matrix metalloproteinases (MMPs). Clarithromycin (CAM) has been reported to suppresses MMP activity. In this study, we investigated whether CAM could prevent the formation and rupture of AA. METHODS: Male apolipoprotein E-deficient mice (28-30 weeks of age) were infused with angiotensin II for 28 days. CAM (100 mg/kg/d) or saline (as a control) was administered orally to the mice every day (CAM group, n = 13; control group, n = 13). After the administration period, the aortic diameter, elastin content, macrophage infiltration, MMP levels, and levels of inflammatory cytokines, including nuclear factor κB (NF-κB), were measured. RESULTS: The aortic diameter was significantly suppressed in the CAM group (P < .001). No rupture death was observed in the CAM group in contrast to five deaths (38%) in the control group (P < .01). CAM significantly suppressed the degradation of aortic elastin (56.3% vs 16.5%; P < .001) and decreased the infiltration of inflammatory macrophages (0.05 vs 0.16; P < .01). Compared with the controls, the enzymatic activity of MMP-2 and MMP-9 was significantly reduced in the CAM group (MMP-2, 0.15 vs 0.56 [P < .01]; MMP-9, 0.12 vs 0.60 [P < .01]), and the levels of interleukin 1β (346.6 vs 1066.0; P < .05), interleukin 6 (128.4 vs 346.2; P < .05), and phosphorylation of NF-κB were also decreased (0.3 vs 2.0; P < .01). CONCLUSIONS: CAM suppressed the progression and rupture of AA through the suppression of inflammatory macrophage infiltration, a reduction in MMP-2 and MMP-9 activity, and the inhibition of elastin degradation associated with the suppression of NF-κB phosphorylation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Uchida W, Narita Y, Yamawaki-Ogata A, et al. The oral administration of clarithromycin prevents the progression and rupture of aortic aneurysm. J Vasc Surg. 2018. PMID: 29550174. doi:10.1016/j.jvs.2017.12.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。